Xeris Biopharma Holdings, Inc (XERS)
NGS · Common · CUSIP 98422E103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for XERS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
98422E103 (prev. 98422L107 )
Market Cap
Small Cap
IPO
6/21/2018 · $15.00/share
Previous Name
Xeris Pharmaceuticals, Inc.
Business: Xeris Biopharma Holdings, Inc, Inc. is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables.

Company Contact

CEO
john Shannon
CFO
Steve Pieper
Headquarters
1375 West Fulton Street, Suite 1300, Chicago, IL 60607
Phone
844-445-5704
Investor Relations
Allison Wey · 844-445-5704 · awey@xerispharma.com
General Email
info@xerispharma.com
SEC EDGAR Filings
View filings »